ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17 | -99.7% | 99,893 | +284.6% | 0.00% | – |
| Q3 2022 | $5,000 | -96.3% | 25,970 | -88.4% | 0.00% | -100.0% |
| Q4 2021 | $136,000 | -31.7% | 224,561 | +9.6% | 0.01% | -22.2% |
| Q3 2021 | $199,000 | -39.0% | 204,870 | -40.8% | 0.02% | -21.7% |
| Q1 2021 | $326,000 | +951.6% | 346,296 | +772.7% | 0.02% | +360.0% |
| Q3 2020 | $31,000 | -27.9% | 39,683 | +92.7% | 0.01% | +150.0% |
| Q1 2019 | $43,000 | -44.2% | 20,588 | -14.1% | 0.00% | -33.3% |
| Q2 2018 | $77,000 | -82.6% | 23,963 | -76.1% | 0.00% | -87.0% |
| Q4 2017 | $442,000 | – | 100,363 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |